Notably, the activated AKT promotes NRF2 translocation to the nucleus and then the transactivation of the downstream target genes, inhibiting oxidative stress in HFD‐induced obesity (Li et al. 2020; Liu et al. 2016). The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.